Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection

HENDERSON, Nev.--(BUSINESS WIRE)--Oct. 23, 2018-- Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news